AI Financial notified of Nasdaq minimum bid price deficiency, has 180 days to cure
AI Financial Corporation received notice from Nasdaq on July 1, 2026, that it has failed to maintain the minimum closing bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2), with the deficiency occurring over 30 consecutive business days through June 30, 2026. The company has until December 28, 2026—180 calendar days—to regain compliance by achieving a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. The stock continues to trade on Nasdaq Capital Market under ticker AIFC; if the company does not cure by the deadline, Nasdaq may grant a second 180-day compliance period, after which delisting determination could follow.
Key facts
- Nasdaq notification issued July 1, 2026
- Minimum closing bid price requirement: $1.00 per share under Nasdaq Listing Rule 5550(a)(2)
- 30 consecutive business days of non-compliance through June 30, 2026
- Cure deadline: December 28, 2026 (180 calendar days)
- Required cure: closing bid price of at least $1.00 per share for 10 consecutive business days
- Potential second cure period: additional 180 days if certain conditions met
- Company considering reverse stock split among available options to regain compliance
- No immediate effect on listing or trading; stock continues to trade under symbol AIFC
Why it matters
AI Financial has a defined compliance window before facing potential delisting; failure to cure by December 28, 2026, could trigger additional compliance periods or, ultimately, a delisting determination subject to appeal.
Developing story
- NT 10-Q
- 8-Kthis filing
Share
Derived from 8-K filed 2026-07-02. Not investment advice. View the source filing on SEC.gov →